about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerConcise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetInitiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells.Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular SimulationMucin1 expression in focal epidermal dysplasia of actinic keratosis.Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma modelCD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings.Role of Pericellular Matrix in the Regulation of Cancer Stemness.Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.Tumor homing indocyanine green encapsulated micelles for near infrared and photoacoustic imaging of tumors.CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.Myosin 1g Contributes to CD44 Adhesion Protein and Lipid Rafts Recycling and Controls CD44 Capping and Cell Migration in B Lymphocytes.Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia.Expression and correlation of CD44 and GP73 in cerebroma tissues.The biology and role of CD44 in cancer progression: therapeutic implications.
P2860
Q26773907-BD1EB91B-9C42-4C88-936B-11BBA8C3AF26Q28083115-43B0567F-3C94-4882-A07E-388FF99B348CQ33711746-FC79ED6C-8EEB-4A45-BD86-2038A5CE54E5Q35746730-91585F7E-7485-45B8-B8A6-4E282291BAF5Q35852033-D1A9F4D2-F581-48CA-A9EF-F525C612BE87Q36762341-7F54D724-4BCC-483F-B101-DF815AB1E3F2Q38705954-B80D7F89-C57B-45BE-A8AE-55687F384E37Q38770102-2750805F-225A-40AC-9D84-215A383F8B7FQ38788951-C70DFC1D-29B5-40C1-875F-E657CF771F79Q38822287-5179A4A6-CE05-40CB-B303-F6DAC7C550C9Q38895042-469397AA-AD91-4BAE-B49F-41AFD693A45EQ38928173-78B0F16A-F7EB-4FBB-9CD6-F1A1A44050ABQ42815766-1F585D47-50FE-494E-BE81-164243E3DAA3Q43376023-57548831-DC99-4C16-9D74-67ED9E477F20Q47847529-7C19CAB2-802A-4AF1-B48E-49E0FE91F5CDQ49177430-E6C434F9-9398-4EFD-9BB4-303A92CFBA4CQ51107775-0A1230B4-6B5C-4C3B-BD64-810DC36FDB22Q52355144-E88949A5-AFFF-47BE-8FBA-6A38B0931D55Q54110894-AB5653F4-1301-4112-B4FE-5CFF7F741798
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Perspectives of CD44 targeting therapies.
@en
type
label
Perspectives of CD44 targeting therapies.
@en
prefLabel
Perspectives of CD44 targeting therapies.
@en
P2860
P1476
Perspectives of CD44 targeting therapies.
@en
P2093
P2860
P2888
P356
10.1007/S00204-014-1424-2
P577
2014-12-05T00:00:00Z
P6179
1033128567